24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

NCT00555789 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: AEB071
DRUG: mycophenolic plus tacrolimus

Sponsor

Novartis Pharmaceuticals